Skip to main content
. 2022 Jan 29;19(3):1575. doi: 10.3390/ijerph19031575

Table 1.

Baseline characteristics of normotensive and hypertensive patients.

Normotensive Hypertensive p-Value Total
(n = 128) (n = 119) (n = 247)
Age (years) 36.6 ± 9.3 41.7 ± 9.5 <0.001 39.1 ± 9.7
Women (%) 100 (78%) 87 (73%) 0.376 187 (76%)
Smoker (%) 0.067
Current 21 (16%) 16 (13%) 37 (15%)
Ex 2 (2%) 9 (8%) 11 (5%)
Body mass index (kg/m2) 46.7 ± 7.9 48.8 ± 7.8 0.040 47.7 ± 7.9
Systolic BP (mmHg) 120 ± 5.4 151 ± 15.7 <0.001 135 ± 19.3
Diastolic BP (mmHg) 79 ± 4.1 94 ± 10.9 <0.001 86 ± 11.1
Glucose (mg/dL) 102 ± 30.9 127 ± 50.7 <0.001 114 ± 43.4
HbA1C (%) 7.1 ± 0.6 7.5 ± 1.0 0.011 7.4 ± 0.9
Hyperuricemia (mg/dL) 5.2 ± 1.3 5.3 ± 1.3 0.496 5.3 ± 1.3
Total Cholesterol (mg/dL) 186 ± 40.5 199 ± 40.9 0.013 192 ± 41.2
LDL Cholesterol (mg/dL) 119 ± 29.8 123 ± 33.7 0.398 121 ± 31.7
HDL Cholesterol (mg/dL) 49 ± 10.8 46 ± 9.8 0.043 47 ± 10.4
Triglycerides (mg/dL) * 122 (99; 149) 128 (102; 160) 0.170 125 (101; 156)
Dyslipidaemia (%) 86 (67%) 94 (79%) 0.045 180 (73%)
Type 2 diabetes mellitus (%) 38 (30%) 70 (59%) <0.001 108 (44%)
Polymedicated patients 16 (13%) 58 (49%) <0.001 74 (30%)
Number of comorbidities
0–2 70 (54.6%) 31 (26.6%) <0.001
3–5 54 (42.3%) 49 (41.1%)
>5 4 (3.1%) 38 (32.8%)

Data are given as mean ± SD or percentage (%), except: * median (P25; P75).